Q&A: In­sitro CEO Daphne Koller on ‘po­ten­tial­ly de­struc­tive’ AI hype, Nvidi­a's chips, and biotech's da­ta prob­lem

SAN JOSE, CA — For all its promise, ar­ti­fi­cial in­tel­li­gence has rou­tine­ly fall­en in­to the hype trap.

Daphne Koller, a self-de­scribed “OG AI per­son,” hopes biotech can steer clear this time around, while not be­ing par­tic­u­lar­ly op­ti­mistic her­self about the chances of tamp­ing down ex­cite­ment to healthy lev­els. Koller, 55, has been work­ing in AI for about three decades, start­ing as a Stan­ford Uni­ver­si­ty pro­fes­sor in 1995 and join­ing Al­pha­bet’s biotech Cal­i­co Life Sci­ences as its chief com­put­ing of­fi­cer in 2016.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER